XML 47 R31.htm IDEA: XBRL DOCUMENT
v3.25.4

Note 18 - Share Incentive Plans | 12 Months Ended
--- | ---
Dec. 31, 2025
Notes to Financial Statements |
Share-Based Payment Arrangement [Text Block] | Note 18. Share Incentive Plans On March 22, 2021, the Company’s Board of Directors adopted the Turning Point Brands, Inc. 2021 Equity Incentive Plan (the “2021 Plan”), pursuant to which awards may be granted to employees, non-employee directors, and consultants. In addition, the 2021 Plan provides for the granting of nonqualified stock options to employees of the Company or any subsidiary of the Company. Pursuant to the 2021 Plan, 1,290,000 shares, plus 100,052 shares remaining available for issuance under the 2015 Equity Incentive Plan (the “2015 Plan”), of TPB Common Stock are reserved for issuance as awards to employees, non-employee directors, and consultants as compensation for past or future services or the attainment of certain performance goals. The 2021 Plan is scheduled to terminate on March 21, 2031. The 2021 Plan is administered by the compensation committee (the “Committee”) of the Company’s Board of Directors. The Committee determines the vesting criteria for the awards, with such criteria to be specified in the award agreement. As of December 31, 2025, net of forfeitures, there were 437,024 Restricted Stock Units (“RSUs”), 122,570 options and 94,421 Performance Based Restricted Stock Units (“PRSUs”) granted under the 2021 Plan. There are 736,037 shares available for future grant under the 2021 Plan. On April 28, 2016, the Board of Directors of the Company adopted the 2015 Plan, pursuant to which awards could have been granted to employees, non-employee directors, and consultants. In addition, the 2015 Plan provided for the granting of nonqualified stock options to employees of the Company or any subsidiary of the Company. Upon adoption of the 2021 Plan, the 2015 Plan was terminated, and the Company determined no additional grants would be made under the 2015 Plan. However, all awards issued under the 2015 Plan that have not been previously terminated or forfeited remain outstanding and continue unaffected. There are no shares available for grant under the 2015 Plan. Stock option activity for the 2015 and 2021 Plans is summarized below:
|  |  |  |  |  | Weighted |  |  | Weighted |
|  | Stock |  |  | Average |  |  | Average |
|  | Option |  |  | Exercise |  |  | Grant Date |
|  | Shares |  |  | Price |  |  | Fair Value |
Outstanding, December 31, 2023 |  |  | 656,951 |  |  | $ | 29.79 |  |  | $ | 9.18 |
Granted |  |  | 54,289 |  |  |  | 27.19 |  |  |  | 9.21 |
Exercised |  |  | (132,572 | ) |  |  | 21.36 |  |  |  | 6.97 |
Forfeited |  |  | (42,878 | ) |  |  | 38.11 |  |  |  | 11.94 |
Outstanding, December 31, 2024 |  |  | 535,790 |  |  | $ | 30.69 |  |  | $ | 9.51 |
Exercised |  |  | (245,855 | ) |  |  | 30.76 |  |  |  | 9.54 |
Forfeited |  |  | (2,643 | ) |  |  | 36.11 |  |  |  | 10.88 |
Outstanding, December 31, 2025 |  |  | 287,292 |  |  | $ | 30.58 |  |  | $ | 9.47 |
Under the 2015 and 2021 Plans, the total intrinsic value of options exercised during the years ended December 31, 2025, 2024, and 2023, was $12.9 million, $2.6 million, and $0.3 million, respectively. At December 31, 2025, under the 2015 and 2021 Plans, the risk-free interest rate is based on the U.S. Treasury rate for the expected life at the time of grant. The expected volatility is based on the average long-term historical volatilities of peer companies. We intend to continue to consistently use the same group of publicly traded peer companies to determine expected volatility until sufficient information regarding volatility of our share price becomes available or until the selected companies are no longer suitable for this purpose. Due to our limited trading history, we are using the simplified method presented by SEC Staff Accounting Bulletin No. 107 to calculate expected holding periods, which represent the periods of time for which options granted are expected to be outstanding. We will continue to use this method until we have sufficient historical exercise experience to give us confidence in the reliability of our calculations. The fair values of these options were determined using the Black-Scholes option pricing model. The following table outlines the assumptions for options granted under the 2015 Plan.
|  | May 17, |  |  | March 7, |  |  | March 20, |  |  | March 18, |  |  | February 18, |
|  | 2017 |  |  | 2018 |  |  | 2019 |  |  | 2020 |  |  | 2021 |
Number of options granted |  |  | 93,819 |  |  |  | 98,100 |  |  |  | 155,780 |  |  |  | 155,000 |  |  |  | 100,000 |
Options outstanding at December 31, 2025 |  |  | 19,569 |  |  |  | 31,370 |  |  |  | 48,880 |  |  |  | 27,513 |  |  |  | 39,600 |
Number exercisable at December 31, 2025 |  |  | 19,569 |  |  |  | 31,370 |  |  |  | 48,880 |  |  |  | 27,513 |  |  |  | 39,600 |
Exercise price |  | $ | 15.41 |  |  | $ | 21.21 |  |  | $ | 47.58 |  |  | $ | 14.85 |  |  | $ | 51.75 |
Remaining lives |  |  | 1.38 |  |  |  | 2.19 |  |  |  | 3.22 |  |  |  | 4.22 |  |  |  | 5.14 |
Risk free interest rate |  |  | 1.76 | % |  |  | 2.65 | % |  |  | 2.34 | % |  |  | 0.79 | % |  |  | 0.56 | %
Expected volatility |  |  | 26.92 | % |  |  | 28.76 | % |  |  | 30.95 | % |  |  | 35.72 | % |  |  | 28.69 | %
Expected life |  |  | 6.000 |  |  |  | 6.000 |  |  |  | 6.000 |  |  |  | 6.000 |  |  |  | 6.000 |
Dividend yield |  |  | - |  |  |  | 0.83 | % |  |  | 0.42 | % |  |  | 1.49 | % |  |  | 0.55 | %
Fair value at grant date |  | $ | 4.60 |  |  | $ | 6.37 |  |  | $ | 15.63 |  |  | $ | 4.41 |  |  | $ | 13.77 |
The following table outlines the assumptions for options granted under the 2021 Plan.
|  | May 17, |  |  | March 14, |  |  | April 29, |  |  | May 12, |  |  | March 11, |
|  | 2021 |  |  | 2022 |  |  | 2022 |  |  | 2023 |  |  | 2024 |
Number of options granted |  |  | 7,500 |  |  |  | 100,000 |  |  |  | 14,827 |  |  |  | 77,519 |  |  |  | 54,289 |
Options outstanding at December 31, 2025 |  |  | 350 |  |  |  | 14,929 |  |  |  | 3,273 |  |  |  | 47,519 |  |  |  | 54,289 |
Number exercisable at December 31, 2025 |  |  | 350 |  |  |  | 14,929 |  |  |  | 3,273 |  |  |  | 47,519 |  |  |  | 54,289 |
Exercise price |  | $ | 45.05 |  |  | $ | 30.46 |  |  | $ | 31.39 |  |  | $ | 20.71 |  |  | $ | 27.19 |
Remaining lives |  |  | 5.38 |  |  |  | 6.21 |  |  |  | 6.33 |  |  |  | 7.37 |  |  |  | 8.20 |
Risk free interest rate |  |  | 0.84 | % |  |  | 2.10 | % |  |  | 2.92 | % |  |  | 3.41 | % |  |  | 4.06 | %
Expected volatility |  |  | 31.50 | % |  |  | 35.33 | % |  |  | 35.33 | % |  |  | 34.51 | % |  |  | 35.09 | %
Expected life |  |  | 6.000 |  |  |  | 6.000 |  |  |  | 6.000 |  |  |  | 5.186 |  |  |  | 5.186 |
Dividend yield |  |  | 0.63 | % |  |  | 1.01 | % |  |  | 0.98 | % |  |  | 1.61 | % |  |  | 1.26 | %
Fair value at grant date |  | $ | 13.23 |  |  | $ | 10.23 |  |  | $ | 11.07 |  |  | $ | 6.45 |  |  | $ | 9.21 |
The Company has recorded compensation expense related to the options based on the provisions of ASC 718 under which the fixed portion of such expense is determined as the fair value of the options on the date of grant and amortized over the vesting period. The Company recorded compensation expense related to the options of approximately $0.0 million , $0.5 million and $0.7 million for the years ended December 31, 2025, 2024 and 2023, respectively. At December 31, 2025, the options have been fully expensed with zero remaining. PRSUs are restricted stock units subject to both performance-based and service-based vesting conditions. The number of shares of TPB Common Stock a recipient will receive upon vesting of a PRSU is calculated by reference to certain performance metrics related to the Company’s performance over a five-year period. PRSUs will vest on the measurement date, which is no more than 65 days after the performance period provided the applicable service and performance conditions are satisfied. At December 31, 2025, there were 273,098 PRSUs outstanding. The following table outlines the PRSUs granted and outstanding as of December 31, 2025.
|  | February 18, |  |  | March 14, |  |  | May 4, |  |  | March 1, |  |  | April 1, |  |  | March 1, |
|  | 2021 |  |  | 2022 |  |  | 2023 |  |  | 2024 |  |  | 2024 |  |  | 2025 |
Number of PRSUs granted |  |  | 100,000 |  |  |  | 49,996 |  |  |  | 133,578 |  |  |  | 111,321 |  |  |  | 8,242 |  |  |  | 41,137 |
PRSUs outstanding at December 31, 2025 |  |  | 63,340 |  |  |  | 19,617 |  |  |  | 67,511 |  |  |  | 74,899 |  |  |  | 6,594 |  |  |  | 41,137 |
Fair value as of grant date |  | $ | 51.75 |  |  | $ | 30.46 |  |  | $ | 22.25 |  |  | $ | 26.52 |  |  | $ | 29.12 |  |  | $ | 70.34 |
Remaining lives |  |  | - |  |  |  | 1.00 |  |  |  | - |  |  |  | 1.00 |  |  |  | 1.00 |  |  |  | 2.00 |
The Company recorded compensation expense related to the PRSUs of approximately $3.0 million, $3.4 million and $3.0 million in the consolidated statements of income for the years ended December 31, 2025, 2024 and 2023, respectively, based on the probability of achieving the performance condition. Total unrecognized compensation expense related to these awards at December 31, 2025, is $2.2 million, which will be expensed over the service period based on the probability of achieving the performance condition. RSUs are stock units subject to service-based vesting conditions over one to five years. At December 31, 2025, there are 158,919 RSUs outstanding. The following table outlines the RSUs granted and outstanding as of December 31, 2025.
|  | March 14, |  |  | April 29, |  |  | May 5, |  |  | March 1, |  |  | April 1, |  |  | March 3, |  |  | March 3, |  |  | May 8, |  |  | July 14, |
|  | 2022 |  |  | 2022 |  |  | 2023 |  |  | 2024 |  |  | 2024 |  |  | 2025 |  |  | 2025 |  |  | 2025 |  |  | 2025 |
Number of RSUs granted |  |  | 50,004 |  |  |  | 4,522 |  |  |  | 130,873 |  |  |  | 105,257 |  |  |  | 5,495 |  |  |  | 36,843 |  |  |  | 14,921 |  |  |  | 8,464 |  |  |  | 1,341 |
RSUs outstanding at December 31, 2025 |  |  | 16,905 |  |  |  | 1,263 |  |  |  | 29,007 |  |  |  | 47,418 |  |  |  | 3,627 |  |  |  | 35,973 |  |  |  | 14,921 |  |  |  | 8,464 |  |  |  | 1,341 |
Fair value as of grant date |  | $ | 30.46 |  |  | $ | 31.39 |  |  | $ | 22.25 |  |  | $ | 26.52 |  |  | $ | 29.12 |  |  | $ | 70.34 |  |  | $ | 67.02 |  |  | $ | 75.66 |  |  | $ | 74.61 |
Remaining lives |  |  | 1.00 |  |  |  | 1.00 |  |  |  | 0.25 |  |  |  | 1.25 |  |  |  | 1.25 |  |  |  | 2.25 |  |  |  | 0.25 |  |  |  | 0.50 |  |  |  | 2.69 |
The Company has recorded compensation expense related to the RSUs based on the provisions of ASC 718 under which the fixed portion of such expense is determined as the fair value of the RSUs on the date of grant and amortized over the vesting period. The Company recorded compensation expense related to the RSUs of approximately $3.9 million, $3.3 million and $2.9 million for the years ended December 31, 2025, 2024 and 2023, respectively. Total unrecognized compensation expense related to RSUs at December 31, 2025, is $2.2 million, which will be expensed over 1.6 years.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration